0.4720
-0.0055
(-1.15%)
As of 11:08:19 AM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALISKI WILLIAM E Director | Stock Award(Grant) | Jun 10, 2024 | 96,667 |
| BALDRY MARK Officer | Sale | Oct 7, 2024 | 48,509 |
| DIBIASE MARY Chief Operating Officer | Sale | Oct 7, 2024 | 452,060 |
| LAWTON ALISON FRANCES Director | Stock Award(Grant) | Jun 10, 2024 | 96,667 |
| MCGIRR DAVID W J Director | Stock Award(Grant) | Jun 10, 2024 | 96,667 |
| MOSTAFA ADAM S. Chief Financial Officer | Sale | Oct 7, 2024 | 0 |
| RAGAN PAULA Chief Executive Officer | Sale | Nov 15, 2024 | 993,919 |
| STEWART MURRAY Director | Stock Award(Grant) | Jun 10, 2024 | 191,504 |
| TAVERAS ARTHUR PHD Officer | Sale | Oct 7, 2024 | 388,026 |
| WYZGA MICHAEL S Director | Stock Award(Grant) | Jun 10, 2024 | 121,667 |
Related Tickers
PDSB PDS Biotechnology Corporation
1.5080
-2.71%
MREO Mereo BioPharma Group plc
2.9250
+0.52%
INZY Inozyme Pharma, Inc.
1.4050
-0.36%
EYEN Eyenovia, Inc.
0.0551
-3.50%
CGTX Cognition Therapeutics, Inc.
0.7481
-0.77%
MCRB Seres Therapeutics, Inc.
0.8458
-1.89%
ALXO ALX Oncology Holdings Inc.
1.4650
-3.30%
NBY NovaBay Pharmaceuticals, Inc.
0.7056
-1.68%
XLO Xilio Therapeutics, Inc.
0.7549
-7.95%
BTAI BioXcel Therapeutics, Inc.
0.3316
-2.47%